过导管心腔隔膜缺陷和孔封闭:医疗保险使用和补偿
Vidit Majmundar1, Rohan Deo1, Ajay Kumar Mishra2
1Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01608, United States.
World journal of methodology
|September 3, 2025
概括
从2013年到2022年,通过导管隔膜缺陷 (ASD) 和孔封闭程序的医疗保险使用率增加了81%. 尽管治疗量较高,但每例治疗费用却下降了18%.
科学领域:
- 心血管干预
- 医疗服务研究
- 医疗设备的使用
背景情况:
- 对心房隔膜缺陷 (ASD) 和孔膜 (PFO) 的皮肤封闭装置是FDA批准的,用于特定的疾病.
- 指示包括血液动力学显著的突变,矛盾的栓塞 (例如中风) 和减压疾病.
- 对于医疗保健政策和设备制造商来说, 了解使用和报销趋势至关重要.
研究的目的:
- 分析医疗保险受益者使用过导管ASD/PFO关闭装置的趋势.
- 检查2013年至2022年这些手术的医疗保险退款趋势.
- 确定影响程序数量和退款率的因素.
主要方法:
- 从医疗保险和医疗补助服务中心 (CMS) 国家总结数据档案B部分 (2013-2022) 中使用的行政数据.
- 根据2023年消费者价格指数对通胀进行调整的报销数据.
- 使用年增长率和简单的线性回归分析量化趋势.
主要成果:
- 从2013年到2022年,跨导管ASD/PFO关闭程序的年增长率为81%,年平均增长率为44%.
- 每个病例的医疗保险补偿金减少了18% (2013年为1128.80美元,到2022年为770.21美元).
- 2020年 (COVID-19大流行) 程序出现了显著的下降,随后在2021-2022年出现了反弹.
结论:
- 从2013年到2022年,医疗保险对跨导管ASD/PFO闭合疗法的使用量显著增加.
- 这种使用率的增加伴随着每例补偿金的同时下降.
- 这些发现突显了医疗保险系统内心血管器械使用和退款的发展趋势.
相关概念视频
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Cardiac Catheterization I: Pre-Procedure Overview
153
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28


